23 Jul, 2026
According to Straits Research, the tendonitis treatment market size was valued at $238.26 billion in 2025 and is projected to grow from $244.83 billion in 2026 to $313.00 billion by 2034 at a CAGR of 3.12% during the forecast period 2026-2034.
Tendonitis is an inflammation or irritation of the tendon, a flexible but inelastic tissue cord connecting bone to muscle. Tendonitis is acute. Tendonitis causes pain, limited mobility, and diminished muscle strength. Tendonitis causes tenderness, frozen shoulder, and edemas.
Tendonitis affects the knees, elbows, heels, shoulders, thumb bases, Achilles tendon, and wrists. Swimmer's shoulder, golfer's elbow, tennis elbow, and jumper's knee are frequent types of tendonitis. Tendonitis can be induced by exercise- or work-related injuries. Most at risk are older adults, especially athletes. Tendonitis must be treated appropriately to avoid tendon ruptures and progressive tendinosis. Untreated tendinitis can cause tendonitis.
Increased sports participation is a leading cause of soft tissue injuries globally and a major market driver. Work opportunities and a desire for fitness have led more people to choose sports as a job or hobby. It could hurt them. Achilles tendinopathy affects 40.0% to 50% of competitive runners, a study found.
Tendonitis is growing more common (5-10 instances per 100,000), which will boost tendonitis treatment sales. Physical therapy, over-the-counter pain medications, and surgical procedures have surged in popularity, fueling market development.
Tendonitis is an inflammation or infection of a thick fibrous cord connecting muscle and bone. This condition is more common in older populations. As the world's population ages, the tendonitis treatment market should expand.
Well-aligned connective tissue allows muscles to move bone. Average annual tendon injuries are 32 million. Tendinopathies account for 50% of all sports-related injuries due to an ageing population. This drives the global tendonitis treatment market.
The number of people participating in sports has increased, which aligns with the trend toward a healthy lifestyle. Despite this, more people are considering sports careers. These factors have increased the number of sports events held worldwide, which has increased the likelihood of athlete injuries. Businesses involved in the global tendonitis treatment market are expected to profit from this scenario. This will create market opportunities.
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa make up the global tendonitis treatment market.
Due to an increase in tendinitis surgeries and disposable income, Asia-Pacific dominated the tendonitis treatment market in 2021, accounting for 71% of the revenue. The region's tendonitis treatment market has great growth potential due to the increasing number of local medical device manufacturers and tendonitis sufferers. Other market drivers include ongoing research, an increase in tendonitis treatment drugs in China and Japan, and an increase in sports injuries.
Lain America is predicted to have the greatest CAGR, at 3.87 percent. Latin America's large number of medical facilities and hospitals that offer tendonitis patients surgical and therapeutic choices is a key element in the market's growth. Several highly regarded surgeons, physicians, and other medical experts from foreign nations have partnered with Latin American hospitals to establish revolutionary treatment methods.
In North America, huge players and increasing healthcare spending will fuel growth. The market will grow. North America has a more aware people than other places.
sales@straitsresearch.com